Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Biomarker for Development of Type 2 Diabetes: 11Beta-Hydroxy Steroid Dehydrogenase Type 1 Activity

NCT02326129 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02326129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Biomarker for Development of Type 2 Diabetes: 11Beta-Hydroxy Steroid Dehydrogenase Type 1 Activity
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
April 5, 2023
Enrollment
202 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type ii